Summary
Aurobindo Pharma announced that the US Food and Drug Administration (USFDA) concluded its routine inspection of its subsidiary Lannett Company LLC's facility in Seymour, USA, noting four procedural observations. The company plans to respond to the USFDA within the stipulated timeframe.